Common Stock, Shares, Outstanding of NIKA PHARMACEUTICALS, INC from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NIKA PHARMACEUTICALS, INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • NIKA PHARMACEUTICALS, INC Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 1,039,836,001, a 2.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

NIKA PHARMACEUTICALS, INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,039,836,001 +21,316,501 +2.1% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 1,026,406,001 +7,886,501 +0.77% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 1,026,371,000 +150,281,000 +17% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 876,090,000 0 0% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 1,018,519,500 +142,429,500 +16% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 1,018,519,500 +142,429,500 +16% 30 Jun 2024 10-Q/A 01 Nov 2024 2024 Q2
Q1 2024 876,090,000 0 0% 31 Mar 2024 10-Q 28 May 2024 2024 Q1
Q4 2023 876,090,000 0 0% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 876,090,000 30 Sep 2023 10-Q 31 Oct 2023 2023 Q3
Q2 2023 876,090,000 0 0% 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 876,090,000 +862,887,000 +6536% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 876,090,000 +480,000,000 +121% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q2 2022 876,090,000 +862,887,000 +6536% 30 Jun 2022 10-Q/A 07 Nov 2022 2022 Q2
Q1 2022 13,203,000 0 0% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 396,090,000 +382,887,000 +2900% 31 Dec 2021 10-K 10 Apr 2023 2022 FY
Q3 2021 13,203,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 13,203,000 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 13,203,000 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 13,203,000 0 0% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q4 2019 13,203,000 31 Dec 2019 10-K 24 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.